文献速递白内障与屈光手术角膜与眼表疾病

青少年及成人JIA相关或ANA阳性前葡萄膜炎患者白内障手术联合IOL植入的预后分析

Outcome after cataract surgery with IOL implantation in adolescents and adults with juvenile idiopathic arthritis (JIA) associated or ANA-positive anterior uveitis.
PubMed 文献 · Br J Ophthalmol · 2026-08-13

该回顾性研究分析了83例(93眼)青少年及成人JIA相关或ANA阳性前葡萄膜炎患者行白内障手术联合IOL植入的视觉预后、葡萄膜炎病程及并发症。术后2年BCVA(logMAR)从术前1.57±1.32改善至0.42±0.83(p<0.001),但术后并发症常见,包括后囊膜混浊(51.9%)、巨细胞沉积(35.7%)和后粘连形成(30%)。术前视力差和高激光闪辉值是视觉预后不良的显著预测因素,而术后并发症的预测因素还包括缺乏全身抗炎药物使用。

要点

  • JIA相关或ANA阳性前葡萄膜炎患者白内障术后2年视力显著改善(BCVA logMAR从1.57降至0.42)。
  • 术后常见并发症包括后囊膜混浊(51.9%)、巨细胞沉积(35.7%)和后粘连(30%)。
  • 术前视力差和高激光闪辉值预测视力预后不良,缺乏全身抗炎药物使用预测术后并发症。

核心结论

  • 青少年及成人JIA相关或ANA阳性前葡萄膜炎患者行白内障手术联合IOL植入可获得有益结局。
  • 重要前提包括术前葡萄膜炎静止、合适的手术技术以及使用DMARDs维持长期葡萄膜炎静止。

研究设计与样本

  • 回顾性分析83例患者(93眼)的临床数据,其中84%为女性,平均年龄24.8±16.2岁。
  • 84%患者为JIA相关前葡萄膜炎,16%为ANA阳性前葡萄膜炎。
  • 分析术前及术后6周、1年、2年的数据,遵循SUN标准。
  • 手术采用小切口、超声乳化及IOL植入,并根据葡萄膜炎相关形态异常调整手术技术。
  • 分析2年随访时视觉预后和视力威胁并发症的预测因素。

主要发现

  • 术前95.7%的眼存在葡萄膜炎相关并发症(如纤维性晶状体膜、后粘连和瞳孔收缩)。
  • BCVA(logMAR)从术前1.57±1.32改善至术后2年0.42±0.83(p<0.001)。
  • 术后并发症包括后粘连形成(30%)、巨细胞沉积(35.7%)、后囊膜混浊(51.9%)和黄斑水肿(12.7%)。
  • 视觉预后不良的显著术前预测因素包括视力差和高激光闪辉值(p<0.05)。
  • 术后眼部并发症的显著预测因素包括视力差和缺乏全身抗炎药物使用(p<0.05)。

临床怎么用

  • 对于JIA相关或ANA阳性前葡萄膜炎患者的白内障手术,应确保术前葡萄膜炎静止并采用合适的手术技术。
  • 术后需使用DMARDs维持长期葡萄膜炎静止,以改善预后。
  • 术前视力差和高激光闪辉值提示视觉预后不良风险增高,需加强围手术期管理。
  • 缺乏全身抗炎药物使用与术后并发症风险增加相关,应重视全身抗炎治疗。

局限性

  • 回顾性研究设计可能引入选择偏倚和信息偏倚。
  • 样本量有限(93眼),可能影响统计效能和结果的普遍性。
  • 随访时间仅为2年,长期结局未知。
  • 未设置对照组,无法直接比较不同手术方式或治疗策略的效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Cataract surgery in patients with chronic anterior uveitis may be associated with increased risk for complications and poor outcomes. This study analyses visual outcome, uveitis course and complications after cataract surgery with intraocular lens (IOL) implantation in adolescents and adults with juvenile idiopathic arthritis (JIA)-associated or antinuclear antibodies (ANA)-positive uveitis. METHODS: Data before and at 6 weeks, 1 and 2 years after surgery were retrospectively analysed according to Standardization of Uveitis Nomenclature (SUN) standards. Surgery was performed with small incisions, phacoemulsification and IOL implantation. Surgical technique was adapted to pre-existing uveitis-related morphological abnormalities. Predictors of visual outcome and vision-threatening complications at 2-year follow-up (FU) were analysed. RESULTS: 93 surgeries of 83 patients (84% female; mean age 24.8±16.2 years) with JIA-associated (84%) or ANA-positive (16%) anterior uveitis were analysed. Preoperative treatment included topical steroids, conventional synthetic disease-modifying antirheumatic drugs (csDMARDs; 72.0%) or biological (b) DMARDs (65.6%). Besides cataract, uveitis-related complications (eg, fibrotic lens membrane, posterior synechiae and pupil contraction) were present in 95.7% before surgery. Best-corrected visual acuity (BCVA) in logarithm of the minimum angle of resolution (logMAR) improved from 1.57±1.32 preoperatively to 0.42±0.83 at 2 years (p<0.001). Postoperative complications included posterior synechiae formation (30%), giant-cell deposits (35.7%), posterior capsule opacification (51.9%) and macular oedema (12.7%). Significant preoperative predictors of poor visual outcome included poor BCVA and high laser flare (LF) values, and those of postoperative ocular complications also included poor BCVA and a lack of systemic anti-inflammatory drug use (each, p<0.05). CONCLUSIONS: Beneficial outcomes can be achieved following cataract surgery with IOL implantation in adolescents and adults with JIA-associated or ANA-positive anterior uveitis. Important prerequisites include preoperative inactivity, appropriate surgical technique and sustained long-term uveitis inactivity with the use of DMARDs.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Backes J, Wortmann C, Rothaus K, et al. Outcome after cataract surgery with IOL implantation in adolescents and adults with juvenile idiopathic arthritis (JIA) associated or ANA-positive anterior uveitis. Br J Ophthalmol. 2026. PMID: 42595447. doi:10.1136/bjo-2025-328588

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。